Medtronic’s 780G – Finally! – Gets FDA Approval
Executive Summary
Earlier than expected, but still after a more than three year wait, the company has obtained FDA approval for its flagship insulin delivery system.
You may also be interested in...
‘Closest To What The Pancreas Would Actually Do’: Medtronic Diabetes Execs On Marketing Plans For MiniMed 780G
In this third Exec Chat with leaders at major diabetes companies that presented at ADA’s Scientific Sessions 2023, Medtech Insight interviewed Medtronic diabetes business leaders Ali Dianaty and Jennifer McVean about the company’s marketing strategy for the recently launched MiniMed 780G with meal detection technology, plans for the Simplera disposable CGM, outlook on the consumer market, and more.
Minute Insight: Medtronic Received Medicare Coverage For New MiniMed 780G Insulin Pump
Medtronic has secured coverage to market its recently approved MiniMed 780G insulin pump to eligible Medicare and Medicare Advantage beneficiaries, opening access to more patients after a long delay in bringing the device to the US market.
Medtronic MiniMed 780G Data Shows Simplified Meal Management Helps Users With Glycemic Target
Medtronic announced data at the ADA conference today showing the MiniMed 780G advanced hybrid close loop system’s meal detection technology helps reduce time spent in hyperglycemia.